Here, we provide additional convincing genetic and functional evidence to confirm dominant mutations leading to impaired CHT function as a cause of dHMN phenotypes and demonstrate that an absence of vocal cord involvement in patients with dHMN with upper limb involvement predominating over lower limb does not preclude SLC5A7 CHT involvement. This evidence concerns the gene SLC5A7 and distal hereditary motor neuropathy.